The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines
Abstract Background Falsely labelled, falsified (counterfeit) medicines (FFCm’s) are produced or distributed illegally and can harm patients. Although the occurrence of FFCm’s is increasing in Europe, harm is rarely reported. The European Directorate for the Quality of Medicines & Health-Care (E...
Main Authors: | Marija Anđelković, Einar Björnsson, Virgilio De Bono, Nenad Dikić, Katleen Devue, Daniel Ferlin, Miroslav Hanževački, Freyja Jónsdóttir, Mkrtich Shakaryan, Sabine Walser |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12913-017-2235-y |
Similar Items
-
Commentary: Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
by: Baobin Huang, et al.
Published: (2017-12-01) -
Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
by: Kah Seng Lee, et al.
Published: (2017-05-01) -
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020-05-01) -
Chemometrical analysis of fingerprints for the detection of counterfeit and falsified medicines
by: Custers Deborah, et al.
Published: (2016-12-01) -
Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
by: Kevin Pozsgai, et al.
Published: (2022-09-01)